Direct interactions of human natural killer cells with Cryptococcus neoformans inhibit granulocyte-macrophage colony-stimulating factor and tumor necrosis factor alpha production
暂无分享,去创建一个
S. Wong | J. Murphy | A. Zhou | J. W. Murphy | A. Zhou | S. C. Wong
[1] M. Burdick,et al. Afferent phase production of TNF-alpha is required for the development of protective T cell immunity to Cryptococcus neoformans. , 1996, Journal of immunology.
[2] S. Levitz,et al. gamma Interferon gene expression and release in human lymphocytes directly activated by Cryptococcus neoformans and Candida albicans , 1996, Infection and immunity.
[3] J. Murphy,et al. Direct anticryptococcal activity of lymphocytes from Cryptococcus neoformans-immunized mice , 1995, Infection and immunity.
[4] G. Trinchieri. Interleukin-12: a proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity. , 1995, Annual review of immunology.
[5] A. Bajpai,et al. Target cell-induced inactivation of cytolytic lymphocytes. Role and regulation of CD45 and calyculin A-inhibited phosphatase in response to interleukin-2. , 1994, The Journal of biological chemistry.
[6] Z. Brahmi,et al. Target cell-directed rapid degradation of TNF-α messenger RNA in human cytotoxic T cells , 1994 .
[7] J. Curtis,et al. Effect of granulocyte-macrophage colony-stimulating factor on rat alveolar macrophage anticryptococcal activity in vitro. , 1994, Journal of immunology.
[8] S. Levitz,et al. Direct activity of human T lymphocytes and natural killer cells against Cryptococcus neoformans , 1994, Infection and immunity.
[9] P. Scott,et al. Natural killer cells are a source of interferon gamma that drives differentiation of CD4+ T cell subsets and induces early resistance to Leishmania major in mice , 1993, The Journal of experimental medicine.
[10] G. Trinchieri,et al. Interleukin-12 and its role in the generation of TH1 cells. , 1993, Immunology today.
[11] S. Wong,et al. Direct interactions of human lymphocytes with the yeast-like organism, Cryptococcus neoformans. , 1993, The Journal of clinical investigation.
[12] S. Levitz,et al. Phenotypic and functional characterization of human lymphocytes activated by interleukin-2 to directly inhibit growth of Cryptococcus neoformans in vitro. , 1993, The Journal of clinical investigation.
[13] G. Bancroft,et al. Cytokine enhancement of complement‐dependent phagocytosis by macrophages: synergy of tumor necrosis factor‐α and granulocyte‐macrophage colony‐stimulating factor for phagocytosis of Cryptococcus neoformans , 1992, European journal of immunology.
[14] S. Levitz. Activation of human peripheral blood mononuclear cells by interleukin-2 and granulocyte-macrophage colony-stimulating factor to inhibit Cryptococcus neoformans , 1991, Infection and immunity.
[15] D. Blanchard,et al. Production of granulocyte-macrophage colony-stimulating factor by large granular lymphocytes stimulated with Candida albicans: role in activation of human neutrophil function. , 1991, Blood.
[16] K. Mühlegger,et al. Nonradioactive HLA class II typing using polymerase chain reaction and digoxigenin-11-2'-3'-dideoxy-uridinetriphosphate-labeled oligonucleotide probes. , 1991, Human immunology.
[17] J. Murphy,et al. Murine natural killer cells are fungicidal to Cryptococcus neoformans , 1991, Infection and immunity.
[18] J. Murphy,et al. Responses of murine natural killer cells to binding of the fungal target Cryptococcus neoformans , 1991, Infection and immunity.
[19] J. Murphy,et al. Binding interactions of murine natural killer cells with the fungal target Cryptococcus neoformans , 1991, Infection and immunity.
[20] J. Gasson. Molecular physiology of granulocyte-macrophage colony-stimulating factor. , 1991, Blood.
[21] J. Murphy,et al. Mechanisms of natural resistance to human pathogenic fungi. , 1991, Annual review of microbiology.
[22] Craig W. Reynolds,et al. Cytoplasmic Components of Natural Killer Cells Limit the Growth of Cryptococcus neoformans , 1990, Journal of leukocyte biology.
[23] S. Banks,et al. Granulocyte-macrophage colony-stimulating factor augments human monocyte fungicidal activity for Candida albicans. , 1990, The Journal of infectious diseases.
[24] G. Trinchieri,et al. Biology of Natural Killer Cells , 1989, Advances in Immunology.
[25] J. Murphy,et al. Murine natural killer cell interactions with a fungal target, Cryptococcus neoformans , 1989, Infection and immunity.
[26] G. Trinchieri,et al. Production of hematopoietic colony-stimulating factors by human natural killer cells , 1989, The Journal of experimental medicine.
[27] S. Roncella,et al. Production of colony-stimulating activity by human natural killer cells: analysis of the conditions that influence the release and detection of colony-stimulating activity. , 1989, Blood.
[28] H. Friedman,et al. Tumor necrosis factor induction by Candida albicans from human natural killer cells and monocytes. , 1988, Journal of immunology.
[29] G. Trinchieri,et al. Interaction of Fc receptor (CD16) ligands induces transcription of interleukin 2 receptor (CD25) and lymphokine genes and expression of their products in human natural killer cells , 1988, The Journal of experimental medicine.
[30] G. Toews,et al. Role of natural killer cells in resistance to Cryptococcus neoformans infections in mice. , 1987, The American journal of pathology.
[31] J. Murphy,et al. Natural cellular resistance of beige mice against Cryptococcus neoformans. , 1986, Journal of immunology.
[32] R. Schmickel,et al. The human 18S ribosomal RNA gene: evolution and stability. , 1986, American journal of human genetics.
[33] J. Murphy,et al. Correlation of natural killer cell activity and clearance of Cryptococcus neoformans from mice after adoptive transfer of splenic nylon wool-nonadherent cells , 1986, Infection and immunity.
[34] D. Goeddel,et al. Human lymphotoxin and tumor necrosis factor genes: structure, homology and chromosomal localization. , 1985, Nucleic acids research.
[35] K. Arai,et al. Isolation of cDNA for a human granulocyte-macrophage colony-stimulating factor by functional expression in mammalian cells. , 1985, Proceedings of the National Academy of Sciences of the United States of America.
[36] P. Bohlen,et al. Isolation and characterization of a full-length expressible cDNA for human hypoxanthine phosphoribosyl transferase. , 1983, Proceedings of the National Academy of Sciences of the United States of America.
[37] D J Jolly,et al. Isolation and characterization of a full-length expressible cDNA for human hypoxanthine phosphoribosyl transferase. , 1983, Proceedings of the National Academy of Sciences of the United States of America.
[38] J. Murphy,et al. In vitro reactivity of natural killer (NK) cells against Cryptococcus neoformans. , 1982, Journal of immunology.
[39] J. Murphy,et al. Immunological Unresponsiveness Induced by Cryptococcal Capsular Polysaccharide Assayed by the Hemolytic Plaque Technique , 1972, Infection and immunity.